Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Other Working Capital Changes (2016 - 2025)

CorMedix's Other Working Capital Changes history spans 13 years, with the latest figure at $1.4 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 149.2% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $2.1 million, down 14.09%, while the annual FY2025 figure was $2.1 million, 14.09% down from the prior year.
  • Other Working Capital Changes for Q4 2025 was $1.4 million at CorMedix, up from -$1.1 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $2.2 million in Q2 2024 and bottomed at -$1.1 million in Q3 2025.
  • The 5-year median for Other Working Capital Changes is $10499.0 (2021), against an average of $264597.3.
  • The largest YoY upside for Other Working Capital Changes was 1558.82% in 2021 against a maximum downside of 919.36% in 2021.
  • A 5-year view of Other Working Capital Changes shows it stood at -$515918.0 in 2021, then skyrocketed by 129.18% to $150564.0 in 2022, then skyrocketed by 178.67% to $419578.0 in 2023, then soared by 30.43% to $547252.0 in 2024, then skyrocketed by 149.2% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for CRMD's Other Working Capital Changes are $1.4 million (Q4 2025), -$1.1 million (Q3 2025), and $1.8 million (Q2 2025).